PSY45 PATIENT-REPORTED OUTCOMES USED IN CLINICAL TRIALS OF SYSTEMIC LUPUS ERYTHEMATOSUS: A REVIEW OF SUITABILITY FOR FDA LABELLING CLAIMS
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.2672
https://www.valueinhealthjournal.com/article/S1098-3015(19)35050-8/fulltext
Title :
PSY45 PATIENT-REPORTED OUTCOMES USED IN CLINICAL TRIALS OF SYSTEMIC LUPUS ERYTHEMATOSUS: A REVIEW OF SUITABILITY FOR FDA LABELLING CLAIMS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)35050-8&doi=10.1016/j.jval.2019.09.2672
First page :
Section Title :
Open access? :
No
Section Order :
12348